Cargando…

Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma

BACKGROUND: The change in renal function induced by first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma remains unclear. METHODS: One hundred and thirty-four patients were evaluated. Sunitinib (SU) and sorafenib (SO) were administered to 91 (67.9%) and 43 (32.1%) patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishihara, Hiroki, Kondo, Tsunenori, Fukuda, Hironori, Yoshida, Kazuhiko, Omae, Kenji, Takagi, Toshio, Iizuka, Junpei, Kobayashi, Hirohito, Tanabe, Kazunari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896698/ https://www.ncbi.nlm.nih.gov/pubmed/29140528 http://dx.doi.org/10.1093/jjco/hyx161

Ejemplares similares

Spatial and temporal responses of metastatic renal cell carcinoma lesions to sequential treatments over a 10‐year period
por: Kobayashi, Hirohito, et al.
Publicado: (2018)

Late recurrence of a malignant hypoglycemia-inducing pelvic solitary fibrous tumor secreting high-molecular-weight insulin-like growth factor-II: A case report with protein analysis
por: ISHIHARA, HIROKI, et al.
Publicado: (2016)

Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy
por: Fukuda, Hironori, et al.
Publicado: (2018)

Association between Ureteral Clamping Time and Acute Kidney Injury during Robot-Assisted Radical Cystectomy
por: Ishiyama, Yudai, et al.
Publicado: (2021)

Computed tomography imaging characteristics of clear cell papillary renal cell carcinoma
por: Banno, Taro, et al.
Publicado: (2020)

Perioperative outcomes following robot-assisted partial nephrectomy for renal cell carcinoma according to surgeon generation
por: Toguchi, Makoto, et al.
Publicado: (2022)

Fat-poor angiomyolipoma with cyst-like changes mimicking a cystic renal cell carcinoma: a case report
por: Kobari, Yuki, et al.
Publicado: (2015)

Detection of a peritumoral pseudocapsule in patients with renal cell carcinoma undergoing robot-assisted partial nephrectomy using enhanced MDCT
por: Toguchi, Makoto, et al.
Publicado: (2021)

Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end‐stage renal disease
por: Ishihara, Hiroki, et al.
Publicado: (2020)

Impact of preoperative proteinuria on renal functional outcomes after open partial nephrectomy in patients with a solitary kidney
por: Tachibana, Hidekazu, et al.
Publicado: (2017)

Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis
por: Omae, Kenji, et al.
Publicado: (2017)

Mid-term outcome of transarterial embolization of renal artery pseudoaneurysm and arteriovenous fistula after partial nephrectomy screened by early postoperative contrast-enhanced CT
por: Morita, Satoru, et al.
Publicado: (2020)

Comparison of perioperative outcomes with or without renorrhaphy during open partial nephrectomy: A propensity score-matched analysis
por: Tachibana, Hidekazu, et al.
Publicado: (2018)

Possible abscopal effect in urothelial carcinoma of the upper urinary tract after treatment with immune checkpoint inhibitors
por: Ishiyama, Yudai, et al.
Publicado: (2019)

Bilateral and multiple mixed epithelial and stromal tumors of the kidney: A case report
por: Minoda, Ryo, et al.
Publicado: (2017)

Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma
por: Mizuno, Ryuichi, et al.
Publicado: (2017)

Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
por: Catalano, Martina, et al.
Publicado: (2022)

The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors
por: Zhang, Haoran, et al.
Publicado: (2020)

Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer
por: Yoshida, Kazuhiko, et al.
Publicado: (2019)

Successful Kidney Transplantation for End-Stage Renal Disease in Marfan's Syndrome
por: Ryosaka, Makoto, et al.
Publicado: (2013)

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2016)

Acquired Hypothyroidism in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors
por: Wu, Jialu, et al.
Publicado: (2020)

Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations
por: Wang, Kun, et al.
Publicado: (2023)

Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
por: Suso-Palau, Daniel, et al.
Publicado: (2022)

FDG-PET/CT and CT Findings of a Benign Solitary Fibrous Tumor of the Kidney; Correlation with Pathology
por: Nakajima, Reiko, et al.
Publicado: (2015)

The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ
por: Kakizoe, Manabu, et al.
Publicado: (2014)

Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma
por: Busch, Jonas, et al.
Publicado: (2011)

Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma
por: Lai, Yongchang, et al.
Publicado: (2018)

Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
por: Janisch, Florian, et al.
Publicado: (2021)

Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor
por: Teishima, Jun, et al.
Publicado: (2021)

Prognostic significance of pseudocapsule status in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
por: Xi, Wei, et al.
Publicado: (2021)

The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
por: Buti, Sebastiano, et al.
Publicado: (2022)

Renal capsule metastasis from renal pelvic cancer: a case report
por: Kobayashi, Yasuyuki, et al.
Publicado: (2018)

Biomarkers for tyrosine kinase inhibitors in renal cell cancer
por: Coupe, Nicholas, et al.
Publicado: (2012)

Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis
por: Liu, Feng, et al.
Publicado: (2016)

Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort
por: Ishiyama, Yudai, et al.
Publicado: (2020)

Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
por: Stühler, Viktoria, et al.
Publicado: (2016)

Immunoscore System for Predicting Clinical Outcome of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
por: Yao, Jia-Xi, et al.
Publicado: (2018)

Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6vkfrhnnv6t4ahv4u1kmt2kst9